检索

期
标题
作者
编号 6 (2019)
Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile 146 dysfunction
Kaputovskij A.
PDF
(Rus)
编号 6 (2014)
SILDENAFIL CITRATE IN THE TREATMENT OF MEN WITH ERECTILE DYSFUNCTION
Gamidov S., Ovchinnikov R., Popova A.
PDF
(Rus)
编号 1 (2019)
Safety of tadalafil in patients with cardiovascular comorbidities
Nikitina I., Gaysina G., Galimov S., Bulygin K., Galimova E., Pavlov V.
PDF
(Rus)
编号 4 (2013)
Experience of the use of silodosin in acute urinary retention caused by benign prostatic hyperplasia
Neymark A., Nozdrachyov N.
PDF
(Rus)
编号 2 (2018)
Current role of sildenafil in the management of erectile dysfunction
Akhvlediani N., Matyukhov I.
PDF
(Rus)
编号 3 (2013)
THE EVALUATION OF EFFICACY AND SAFETY OF TREATMENT WITH DALFAZ SR IN PATIENTS WITH PROSTATIC ADENOMA
Rasner P., Yu Pushkar D.
PDF
(Rus)
编号 4 (2017)
Efficacy of tamsulosin for treating lower urinary tract symptoms in patients with advanced prostate cancer
Govorov A., Vasilyev A., Pushkar D.
PDF
(Rus)
编号 2 (2013)
EFFICACY AND SAFETY OF USE OF LIKOPROFIT® IN PATIENTS WITH CHRONIC PROSTATITIS AND PROSTATIC ADENOMA
Spivak L.
PDF
(Rus)
编号 5 (2017)
THE EVIDENCE FOR THE EFFICIENCY AND SAFETY OF DAPOXETINE IN TREATING PREMATURE EJACULATION
Akhvlediani N., Matyukhov I.
PDF
(Rus)
编号 1 (2017)
PHOSPHODIESTERASE TYPE 5 INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION: PAST, PRESENT AND FUTURE
Gamidov S., Ovchinnikov R., Popova A., Izhbaev S.
PDF
(Rus)
编号 2 (2013)
PROFILE OF SILODOSIN
Montorsi F.
PDF
(Rus)
编号 2 (2017)
SOLITARY STONES OF THE LOWER RENAL CALYX: HOW TO TREAT?
Martov A., Ergakov D., Andronov A., Dutov S., Takhaev R., Kil'chukov Z., Moskalenko S.
PDF
(Rus)
编号 2 (2016)
ULTRAMINIPERCUTANEOUS NEPHROLITHOTRIPSY IN TREATING KIDNEY STONES
Martov A., Dutov S., Andronov A.
PDF
(Rus)
编号 2 (2012)
PILOT EXPERIENCE OF PERCUTANEOUS NEPHROLITHOTRIPSY IN DORSAL POSITIONING OF THE PATIENT
Martov A., Andronov A., Dutov S., Stepanov V., Dzhafar-zade M.
PDF
(Rus)
编号 6 (2021)
Fosfomycin: potential and perspectives for use in urological practice
Zaitsev A., Palagin I.
PDF
(Rus)
编号 5 (2015)
MIRABEGRON. WHETHER WILL BE A REVOLUTION IN THE PHARMACOTHERAPY OF OVERACTIVE BLADDER?
Romikh V., Borisenko L., Zakharchenko A.
PDF
(Rus)
编号 2 (2012)
TREATMENT OF CHRONIC PROSTATITIS IN PROPHYLAXIS OF PROSTATIC ADENOMA
Alyaev Y., Vinarov A., Demidko Y., Spivak L.
PDF
(Rus)
编号 4 (2021)
Rationale for the choice of an antibiotic for urinary tract infections with an emphasis on the environmental safety of therapy
Yakovlev S., Suvorova M.
PDF
(Rus)
编号 4 (2015)
New options of endoscopic treatment for kidney and ureter stones in obese patients
Martov A., Dutov S., Andronov A., Kilchukov Z., Tahaev R.
PDF
(Rus)
编号 6 (2010)
Three-year results of a clinical study of prostamol Uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression
Vinarov A., Alyaev Y., Apolikhin O., Mazo E., Darenkov S., Demidko Y., Lokshin K., Medvedev A., Permyakova O., Spivak L., Shkol'nikov M., Vinarov A., Alyaev Y., Apolikhin O., Mazo E., Darenkov S., Demidko Y., Lokshin K., Medvedev A., Permyakova O., Spivak L., Shkolnikov M.
1 - 20 的 20 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##